Q1 adj. EBIT -1% vs ABG, but -10% vs. consensus We cut adj. EBIT by 14-9%, whereof 8% relates to FX Share is trading at 5-3x EBIT adj, 8% dividend yield Still waiting for new games to turn growth trend around Q1 showed similar trends as Q4. Sales declined...

We expect positive organic growth from H2'25 EBIT estimates cut 2%, mainly on FX Share is trading at 6-5x and 10-11% FCF yields on '25e-'27e Improved organic growth from Q2, positive in H2 Q4 saw sales in line with our expectations, for an organic growth...

Q4 due on 13 February Negative organic growth but +14% adj. EBIT y-o-y Share is trading at 6x EV/EBIT in 2025e Q4 expectations We expect the negative organic growth headwinds to continue, but for the margin to improve and earnings adjusted for one-offs...

Q3 weaker, but entering Q4 with better momentum EBIT estimates cut by 3% on '25e-'26e Share is trading at 4x EV/EBIT and EV/FCF on 2025e Weaker sales but strong cash flow G5 delivered Q3 sales 6% below both our and FactSet consensus' expectation, which...

Sales -6%, adj. EBIT -11% vs. FactSet consensus in Q3 We expect consensus to lower EBIT estimates by 2-4% on '25e-'26e Highlights positive momentum m-o-m in October, share trades at 4x EBIT '24e Q3 details Sales SEK 270m (-6% vs ABGSCe 286m and -6% vs...

Negative growth trend persists, but could improve from Q4'24e Potential for continued gross margin improvements Trading at 5x EV/EBIT and 4x EV/FCF on 2024e, 8% div yield Focus on protecting profitability As expected, Q2 was reminiscent of the performance...